000 03497naa a22005057i 4500
001 UMUN-OA-20261005-PH-011
003 local
005 20261005174912.0
006 m o d
007 cr||||||||||||
008 261005s2023 xx o u000 0 eng d
024 7 _a10.1097/hep.0000000000000004
_2doi
035 _a(local)EuropePMC:PMC10026948
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aZobair M Younossi
_eauthor.
245 1 4 _aThe global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. /
_cZobair M Younossi; Pegah Golabi; James M Paik [and others].
264 1 _a[Place of publication not identified] :
_b[publisher not identified],
_c2023.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aBackground and aims NAFLD is a leading cause of liver-related morbidity and mortality. We assessed the global and regional prevalence, incidence, and mortality of NAFLD using an in-depth meta-analytic approach. Approach and results PubMed and Ovid MEDLINE were searched for NAFLD population-based studies from 1990 to 2019 survey year (last published 2022) per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Meta-analysis was conducted using random-effects models. Bias risk assessment was per Joanna Briggs Institute. Of 2585 studies reviewed, 92 studies (N=9,361,716) met eligibility criteria. Across the study period (1990-2019), meta-analytic pooling of NAFLD prevalence estimates and ultrasound-defined NAFLD yielded an overall global prevalence of 30.05% (95% CI: 27.88%-32.32%) and 30.69% (28.4-33.09), respectively. Global NAFLD prevalence increased by +50.4% from 25.26% (21.59-29.33) in 1990-2006 to 38.00% (33.71-42.49) in 2016-2019 ( p Conclusions NAFLD global prevalence is 30% and increasing which requires urgent and comprehensive strategies to raise awareness and address all aspects of NAFLD on local, regional, and global levels.
540 _aCreative Commons Attribution-NonCommercial-NoDerivatives. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by-nc-nd/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Public Health.
653 _aB. Sc. Public Health
653 _aUMUN open access collection
653 _aepidemiology
655 4 _aReview articles.
700 0 _aPegah Golabi
_eauthor.
700 0 _aJames M Paik
_eauthor.
700 0 _aJames M Paik
_eauthor.
700 0 _aAustin Henry
_eauthor.
700 0 _aCatherine Van Dongen
_eauthor.
700 0 _aLinda Henry
_eauthor.
773 0 _tHepatology (Baltimore, Md.)
_gVol. 77, no. 4, (2023), pages/article 1335-1347
_x0270-9139
856 4 0 _uhttps://europepmc.org/articles/PMC10026948
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC10026948
_qlocal
942 _n0
999 _c1283
_d1283